Medtech Innovator announced that it awarded the grand prize for its early-stage accelerator to AI-driven tech developer Samay ...

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating ...

Johnson & Johnson’s medtech acquisitions over the past year have fueled growth for its cardiovascular group, offsetting ...

Abbott Laboratories raised its 2024 earnings guidance after strong Q3 results, driven by growth in Pharma and MedTech ...

Employees at the 10 largest medtech employers in the world are excited about culture but are still frustrated by corporate ...

We recently published a list of 8 High Growth UK Stocks to Invest In. In this article, we are going to take a look at where ...

Definitive Healthcare (Nasdaq: DH), a leader in healthcare commercial intelligence, today announced the launch of Monocl Conferences. This solution is designed to enhance conference planning and ...

Johnson & Johnson beat investors’ expectations despite its medtech unit underperforming, with execs pointing to the Asia-Pacific region as a continued source of struggle. Executives said on the ...

The Impact of the Top 3 Strategic Imperatives on R&D Investment in the Medtech Industry About is the world's leading source for international market research reports and market data. We provide you ...

Event puts focus on medical technologies Oct. 15-17 at the Metro Toronto Convention Centre ...

德克萨斯州沃斯堡 - 专注于外科和伤口护理医疗技术的Sanara MedTech Inc. (NASDAQ: SMTI)今日宣布，James "Jim" Stuckert先生已从公司董事会辞职。Stuckert先生将在离职后继续担任名誉董事。Keith Myers先生已被任命填补董事会的空缺。 Sanara执行主席兼首席执行官Ron Nixon对Stuckert先生多年来的服务和对公司发展的贡献表 ...

Nodenza Venture Partners launchedFocus on international early-stage and pre-commercial biotech & medtech opportunitiesNew York, October 16, ...